Clinical outcome of severe head injury in different protocol-driven therapies

Sheng Jean Huang, Wei Chen Hong, Yin Yi Han, Yuan Sen Chen, Chung Shi Wen, Yi Shin Tsan, Yong Kwang Tu

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

In the past 5 years cerebral perfusion pressure (CPP) management has become mainstream in the treatment of severe head injuries. The American Association of Neurological Surgeons guidelines (2000) suggest that CPP should be maintained at least 70 mmHg; however, there is still debate about optimal CPP level. The purpose of this study is to evaluate the effectiveness of three widely used therapies: intracranial pressure (ICP)-targeted therapy, CPP-targeted therapy with CPP > 70 mmHg, and modified CPP-targeted therapy with CPP > 60 mmHg. The clinical procedures, complications, and patient outcomes are compared. Data including patient age, sex, initial Glasgow Coma Score (GCS), ICP, CPP, fluid status, amount of mannitol and vasopressor used, daily intake and output, complications, and clinical results were collected from 213 patients with severe head injuries over a 12-year period. Patients were categorized into three groups (ICP, CPP, modified CPP [mCPP]) according to treatment protocol used. Retrospective data collection was by chart review. The mortality rate was 28.6%, 14.3%, and 13.5% in groups ICP, CPP, and mCPP, respectively. Highest intake/output ratio, amount of vasopressor used, and pulmonary complication rates were seen in group CPP patients. Group mCPP patients showed the best clinical outcome and lowest complication rate. Though CPP-targeted therapy is the most recommended therapeutic protocol, our data showed that the outcome is as good in the mCPP-targeted group with CPP > 60 mmHg as in the CPP-targeted group, but complications are fewer in the mCPP group.

Original languageEnglish
Pages (from-to)449-454
Number of pages6
JournalJournal of Clinical Neuroscience
Volume14
Issue number5
DOIs
Publication statusPublished - May 1 2007
Externally publishedYes

Fingerprint

Cerebrovascular Circulation
Craniocerebral Trauma
Intracranial Pressure
Therapeutics

Keywords

  • Cerebral perfusion pressure
  • Intracranial hypertension
  • Protocol-driven therapy
  • Severe head injury

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Physiology (medical)

Cite this

Clinical outcome of severe head injury in different protocol-driven therapies. / Huang, Sheng Jean; Hong, Wei Chen; Han, Yin Yi; Chen, Yuan Sen; Wen, Chung Shi; Tsan, Yi Shin; Tu, Yong Kwang.

In: Journal of Clinical Neuroscience, Vol. 14, No. 5, 01.05.2007, p. 449-454.

Research output: Contribution to journalArticle

Huang, Sheng Jean ; Hong, Wei Chen ; Han, Yin Yi ; Chen, Yuan Sen ; Wen, Chung Shi ; Tsan, Yi Shin ; Tu, Yong Kwang. / Clinical outcome of severe head injury in different protocol-driven therapies. In: Journal of Clinical Neuroscience. 2007 ; Vol. 14, No. 5. pp. 449-454.
@article{c77aa60d25d149f39084ba8e40af41e1,
title = "Clinical outcome of severe head injury in different protocol-driven therapies",
abstract = "In the past 5 years cerebral perfusion pressure (CPP) management has become mainstream in the treatment of severe head injuries. The American Association of Neurological Surgeons guidelines (2000) suggest that CPP should be maintained at least 70 mmHg; however, there is still debate about optimal CPP level. The purpose of this study is to evaluate the effectiveness of three widely used therapies: intracranial pressure (ICP)-targeted therapy, CPP-targeted therapy with CPP > 70 mmHg, and modified CPP-targeted therapy with CPP > 60 mmHg. The clinical procedures, complications, and patient outcomes are compared. Data including patient age, sex, initial Glasgow Coma Score (GCS), ICP, CPP, fluid status, amount of mannitol and vasopressor used, daily intake and output, complications, and clinical results were collected from 213 patients with severe head injuries over a 12-year period. Patients were categorized into three groups (ICP, CPP, modified CPP [mCPP]) according to treatment protocol used. Retrospective data collection was by chart review. The mortality rate was 28.6{\%}, 14.3{\%}, and 13.5{\%} in groups ICP, CPP, and mCPP, respectively. Highest intake/output ratio, amount of vasopressor used, and pulmonary complication rates were seen in group CPP patients. Group mCPP patients showed the best clinical outcome and lowest complication rate. Though CPP-targeted therapy is the most recommended therapeutic protocol, our data showed that the outcome is as good in the mCPP-targeted group with CPP > 60 mmHg as in the CPP-targeted group, but complications are fewer in the mCPP group.",
keywords = "Cerebral perfusion pressure, Intracranial hypertension, Protocol-driven therapy, Severe head injury",
author = "Huang, {Sheng Jean} and Hong, {Wei Chen} and Han, {Yin Yi} and Chen, {Yuan Sen} and Wen, {Chung Shi} and Tsan, {Yi Shin} and Tu, {Yong Kwang}",
year = "2007",
month = "5",
day = "1",
doi = "10.1016/j.jocn.2005.12.012",
language = "English",
volume = "14",
pages = "449--454",
journal = "Journal of Clinical Neuroscience",
issn = "0967-5868",
publisher = "Churchill Livingstone",
number = "5",

}

TY - JOUR

T1 - Clinical outcome of severe head injury in different protocol-driven therapies

AU - Huang, Sheng Jean

AU - Hong, Wei Chen

AU - Han, Yin Yi

AU - Chen, Yuan Sen

AU - Wen, Chung Shi

AU - Tsan, Yi Shin

AU - Tu, Yong Kwang

PY - 2007/5/1

Y1 - 2007/5/1

N2 - In the past 5 years cerebral perfusion pressure (CPP) management has become mainstream in the treatment of severe head injuries. The American Association of Neurological Surgeons guidelines (2000) suggest that CPP should be maintained at least 70 mmHg; however, there is still debate about optimal CPP level. The purpose of this study is to evaluate the effectiveness of three widely used therapies: intracranial pressure (ICP)-targeted therapy, CPP-targeted therapy with CPP > 70 mmHg, and modified CPP-targeted therapy with CPP > 60 mmHg. The clinical procedures, complications, and patient outcomes are compared. Data including patient age, sex, initial Glasgow Coma Score (GCS), ICP, CPP, fluid status, amount of mannitol and vasopressor used, daily intake and output, complications, and clinical results were collected from 213 patients with severe head injuries over a 12-year period. Patients were categorized into three groups (ICP, CPP, modified CPP [mCPP]) according to treatment protocol used. Retrospective data collection was by chart review. The mortality rate was 28.6%, 14.3%, and 13.5% in groups ICP, CPP, and mCPP, respectively. Highest intake/output ratio, amount of vasopressor used, and pulmonary complication rates were seen in group CPP patients. Group mCPP patients showed the best clinical outcome and lowest complication rate. Though CPP-targeted therapy is the most recommended therapeutic protocol, our data showed that the outcome is as good in the mCPP-targeted group with CPP > 60 mmHg as in the CPP-targeted group, but complications are fewer in the mCPP group.

AB - In the past 5 years cerebral perfusion pressure (CPP) management has become mainstream in the treatment of severe head injuries. The American Association of Neurological Surgeons guidelines (2000) suggest that CPP should be maintained at least 70 mmHg; however, there is still debate about optimal CPP level. The purpose of this study is to evaluate the effectiveness of three widely used therapies: intracranial pressure (ICP)-targeted therapy, CPP-targeted therapy with CPP > 70 mmHg, and modified CPP-targeted therapy with CPP > 60 mmHg. The clinical procedures, complications, and patient outcomes are compared. Data including patient age, sex, initial Glasgow Coma Score (GCS), ICP, CPP, fluid status, amount of mannitol and vasopressor used, daily intake and output, complications, and clinical results were collected from 213 patients with severe head injuries over a 12-year period. Patients were categorized into three groups (ICP, CPP, modified CPP [mCPP]) according to treatment protocol used. Retrospective data collection was by chart review. The mortality rate was 28.6%, 14.3%, and 13.5% in groups ICP, CPP, and mCPP, respectively. Highest intake/output ratio, amount of vasopressor used, and pulmonary complication rates were seen in group CPP patients. Group mCPP patients showed the best clinical outcome and lowest complication rate. Though CPP-targeted therapy is the most recommended therapeutic protocol, our data showed that the outcome is as good in the mCPP-targeted group with CPP > 60 mmHg as in the CPP-targeted group, but complications are fewer in the mCPP group.

KW - Cerebral perfusion pressure

KW - Intracranial hypertension

KW - Protocol-driven therapy

KW - Severe head injury

UR - http://www.scopus.com/inward/record.url?scp=33947433167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947433167&partnerID=8YFLogxK

U2 - 10.1016/j.jocn.2005.12.012

DO - 10.1016/j.jocn.2005.12.012

M3 - Article

VL - 14

SP - 449

EP - 454

JO - Journal of Clinical Neuroscience

JF - Journal of Clinical Neuroscience

SN - 0967-5868

IS - 5

ER -